蛋白质工程市场规模、份额和成长分析（按产品、技术、蛋白质类型、最终用途、蛋白质类型、最终用途和地区）- 产业预测 2025-2032

2023 年蛋白质工程市场规模价值 31 亿美元，预计将从 2024 年的 36.4 亿美元成长到 2032 年的 131.3 亿美元，预测期间（2025-2032 年）的复合年增长率为 17.4%。

由于生物製药需求的激增以及对基因工程技术的投资的增加，蛋白质工程市场预计将经历显着增长。增加医学研发的资金，特别是针对慢性病的疫苗和生技药品，将为蛋白质工程提供者创造充足的机会。合成生物学的兴起和蛋白质工程技术的进步预计将进​​一步为业务成长开闢新的途径。此外，全球对个人化医疗和标靶治疗的需求预计将推动蛋白质工程产品和服务的销售。然而，该行业的成长可能面临围绕蛋白质工程的智慧财产权纠纷、对蛋白质稳定性的担忧以及道德问题等挑战，这些挑战可能会阻碍长期发展。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

蛋白质工程市场规模（按产品和复合年增长率） (2025-2032)

• 市场概况
• 装置
• 试剂
• 软体和服务

蛋白质工程市场规模（依技术及复合年增长率） (2025-2032)

• 市场概况
• 合理蛋白质设计
• 定向进化
• 混合方法
• 从头蛋白质设计
• 其他的

蛋白质工程市场规模（按蛋白质类型和复合年增长率） (2025-2032)

• 市场概况
• 胰岛素
• 单株抗体
• 疫苗
• 生长因子
• 集落刺激因子
• 凝血因子
• 干扰素
• 其他的

蛋白质工程市场规模（依最终用途和复合年增长率） (2025-2032)

• 市场概况
• 学术研究所
• 合约研究组织 (CRO)
• 製药和生物技术公司

蛋白质工程市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Thermo Fisher Scientific Inc.（US）
• Merck KGaA（Germany）
• Agilent Technologies, Inc.（US）
• Genscript Biotech Corporation（China）
• Codexis, Inc.（US）
• Danaher Corporation（US）
• Bio-Rad Laboratories, Inc.（US）
• Bruker Corporation（US）
• PerkinElmer, Inc.（US）
• Twist Bioscience Corporation（US）
• New England Biolabs（US）
• Genentech, Inc.（US）
• Promega Corporation（US）
• Sutro Biopharma, Inc.（US）
• Abcam plc.（UK）
• Cyrus Biotechnology, Inc.（US）
• Profacgen（US）
• Creative Biomart（US）
• SeSaM-Biotech GmbH（Germany）

结论和建议

Protein Engineering Market size was valued at USD 3.1 billion in 2023 and is poised to grow from USD 3.64 billion in 2024 to USD 13.13 billion by 2032, growing at a CAGR of 17.4% during the forecast period (2025-2032).

The protein engineering market is poised for significant growth, driven by the surging demand for biopharmaceuticals alongside escalating investments in genetic engineering technologies. Increased funding for medical R&D, particularly for vaccines and biologics targeting chronic diseases, is set to create ample opportunities for protein engineering providers. The rise of synthetic biology and advancements in protein engineering techniques will further open new avenues for business growth. Additionally, the global demand for personalized medicine and targeted therapies is anticipated to boost the sale of protein engineering products and services. However, industry growth may face challenges from intellectual property disputes, protein stability concerns, and ethical issues surrounding protein engineering, which could hinder development in the long term.

Top-down and bottom-up approaches were used to estimate and validate the size of the Protein Engineering market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Protein Engineering Market Segments Analysis

Global Protein Engineering Market is segmented by Product, Technology, Protein Type, End Use and region. Based on Product, the market is segmented into Instruments, Reagents and Software & Services. Based on Technology, the market is segmented into Rational Protein Design, Directed Evolution, Hybrid Approach, De Novo Protein Design and Others. Based on Protein Type, the market is segmented into Insulin, Monoclonal Antibodies, Vaccines, Growth Factors, Colony Stimulating Factors, Coagulation Factors, Interferon and Others. Based on End Use, the market is segmented into Academic Research Institutes, Contract Research Organizations (CROs) and Pharmaceutical &biotechnology companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Protein Engineering Market

The rising trend of personalized medicine has gained significant traction globally, as individuals seek more targeted and effective treatment options for their health issues. As the understanding of genetic influences on diseases becomes increasingly refined, the demand for personalized therapeutic solutions has surged. This evolution in medical treatment is heavily reliant on protein engineering, which is essential for creating tailored therapies. Consequently, the expanding interest in personalized medicine directly contributes to the growth and expansion opportunities for companies operating within the protein engineering sector, highlighting the interdependence between these two fields in advancing healthcare innovation.

Restraints in the Protein Engineering Market

The Protein Engineering market faces significant challenges primarily due to the complexities involved in achieving desirable stability and functionality in proteins. The intricate nature of proteins makes it difficult to preserve their therapeutic properties, as they are prone to denaturation or aggregation. Such alterations can significantly diminish their effectiveness, hindering the development of innovative protein-based products. Consequently, these challenges may impede the growth potential of the market, as efforts to create stable and functional proteins are met with obstacles that complicate research and development within this sector, ultimately affecting overall market progress.

Market Trends of the Protein Engineering Market

The protein engineering market is witnessing a significant trend towards the adoption of directed evolution techniques, which leverage principles of natural selection in laboratory settings. This innovative approach enables companies to develop novel protein variants that are not purely synthetic, expanding the potential applications across various domains, including therapeutics for chronic diseases. The ability to rapidly generate diverse protein libraries enhances research capabilities, driving collaborations between academia and industry. As the demand for tailored biopharmaceuticals and precision medicine continues to rise, the incorporation of directed evolution is positioning protein engineering as a key player in addressing complex healthcare challenges, shaping a dynamic market landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Protein Engineering Market Size by Product & CAGR (2025-2032)

• Market Overview
• Instruments
• Reagents
• Software & Services

Global Protein Engineering Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Rational Protein Design
• Directed Evolution
• Hybrid Approach
• De Novo Protein Design
• Others

Global Protein Engineering Market Size by Protein Type & CAGR (2025-2032)

• Market Overview
• Insulin
• Monoclonal Antibodies
• Vaccines
• Growth Factors
• Colony Stimulating Factors
• Coagulation Factors
• Interferon
• Others

Global Protein Engineering Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Academic Research Institutes
• Contract Research Organizations (CROs)
• Pharmaceutical & Biotechnology Companies

Global Protein Engineering Market Size & CAGR (2025-2032)

• North America (Product, Technology, Protein Type, End Use)
  • US
  • Canada
• Europe (Product, Technology, Protein Type, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, Protein Type, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, Protein Type, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, Protein Type, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genscript Biotech Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Codexis, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Twist Bioscience Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genentech, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sutro Biopharma, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abcam plc. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cyrus Biotechnology, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Profacgen (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Biomart (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SeSaM-Biotech GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations